Salubrinal has demonstrated neuroprotection in models of TBI and AD by mitigating ER stress and apoptosis, reducing inflammatory markers like TNF-α and IL-6, and promoting cellular membrane integrity. The gene discussed is TNF; the disease is Alzheimer disease.